Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Clinical Chemistry|April 1, 1993
Increased urinary excretion of pyridinium cross-links in cancer patientsA Lipton, L Demers, Y Daniloff, et al.
European Journal of Cancer (Oxford, England : 1990)|March 10, 1999
Markers of bone resorption in patients treated with pamidronateA Lipton, L Demers, E Curley, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 14, 2003
Serum HER-2/neu and response to the aromatase inhibitor letrozole versus tamoxifenA Lipton, S M Ali, K Leitzel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2002
Elevated serum Her-2/neu level predicts decreased response to hormone therapy in metastatic breast cancerAllan Lipton, S M Ali, K Leitzel, et al.
Journal of the National Cancer Institute. Monographs|August 30, 2000
Tissue-specific synthesis and oxidative metabolism of estrogensC R Jefcoate, J G Liehr, R J Santen, et al.
Analytical Methods : Advancing Methods and Applications|March 28, 2023
Digital image analysis for biothreat detection via rapid centrifugal microfluidic orthogonal flow immunocaptureM Shane Woolf, Leah M Dignan, Scott M Karas, et al.
Microbiology Spectrum|August 4, 2022
Detection and Quantification of the Capsular Polysaccharide of Burkholderia pseudomallei in Serum and Urine Samples from Melioidosis PatientsHaley L DeMers, Teerapat Nualnoi, Peter Thorkildson, et al.
Pathogens (Basel, Switzerland)|August 28, 2021
Development of Immunoassays for Detection of Francisella tularensis Lipopolysaccharide in Tularemia Patient SamplesEmily E Hannah, Sujata G Pandit, Derrick Hau, et al.
Plos Neglected Tropical Diseases|November 3, 2020
Development of an antigen detection assay for early point-of-care diagnosis of Zaire ebolavirusHaley L DeMers, Shihua He, Sujata G Pandit, et al.
British Journal of Cancer|July 15, 2010
The insulin-like growth factor-I receptor inhibitor figitumumab (CP-751,871) in combination with docetaxel in patients with advanced solid tumours: results of a phase Ib dose-escalation, open-label studyL R Molife, P C Fong, L Paccagnella, et al.
Pageof 9